Attached files
| file | filename |
|---|---|
| EXCEL - IDEA: XBRL DOCUMENT - Pacira BioSciences, Inc. | Financial_Report.xls |
| 10-Q - 10-Q - Pacira BioSciences, Inc. | a12-8876_110q.htm |
| EX-31.2 - EX-31.2 - Pacira BioSciences, Inc. | a12-8876_1ex31d2.htm |
| EX-10.1 - EX-10.1 - Pacira BioSciences, Inc. | a12-8876_1ex10d1.htm |
| EX-10.3 - EX-10.3 - Pacira BioSciences, Inc. | a12-8876_1ex10d3.htm |
| EX-32.2 - EX-32.2 - Pacira BioSciences, Inc. | a12-8876_1ex32d2.htm |
| EX-31.1 - EX-31.1 - Pacira BioSciences, Inc. | a12-8876_1ex31d1.htm |
| EX-10.2 - EX-10.2 - Pacira BioSciences, Inc. | a12-8876_1ex10d2.htm |
| EX-10.4 - EX-10.4 - Pacira BioSciences, Inc. | a12-8876_1ex10d4.htm |
Exhibit 32.1
STATEMENT PURSUANT TO 18 U.S.C. §1350
Pursuant to 18 U.S.C. §1350, the undersigned certifies that this Quarterly Report on Form 10-Q of Pacira Pharmaceuticals, Inc. for the quarter ended March 31, 2012 fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 and that the information contained in this report fairly presents, in all material respects, the financial condition and results of operations of Pacira Pharmaceuticals, Inc.
|
Date: May 9, 2012 |
|
/s/ David Stack |
|
|
|
David Stack |
|
|
|
President and Chief Executive Officer |
|
|
|
(Principal Executive Officer) |